Seven in 10 participants reported feeling better, much better, or very much better.

They found median daily urgency urinary incontinence episodes dropped from 4.2 at baseline to 1.7 at 3 months and that remained consistent to 12 months. The investigators looked at bladder diary data and quality of life at 3, 6, and 12 months postactivation. Gilling and colleagues in New Zealand and the US studied 46 patients (45 of whom were women) with refractory overactive bladder syndrome with urgency urinary incontinence implanted with the eCoin. Subsequent stimulation happens automatically without patient involvement. The in-office procedure, done under local anesthesia, takes about 20 minutes.Ī field clinical engineer programs the device according to the individual patient’s sensitivity when the implantation is fully healed, at about 4 weeks. Like percutaneous tibial nerve stimulation, eCoin aims to relieve symptoms of overactive bladder syndrome with urgency urinary incontinence by stimulating the tibial nerve.Ī urologist implants the battery-powered eCoin subcutaneously in the medial lower leg. “eCoin is a fully implantable device with no leads, transducers, electrodes, or control unit necessary,” he said.

Sixty-five percent of patients were considered responders, which is a very competitive result,” Gilling said.īy 12 months, 26% of those studied achieved complete continence.Īnd compared with other neuromodulation techniques, eCoin appears to obviate patient factors that often affect compliance, such as onerous treatment schedules, according to Gilling. “The decrease in incontinence episodes and the durability of the treatment are as good as any of the other available devices and techniques for refractory urge incontinence. A nickel-sized tibial nerve stimulator offers overactive bladder (OAB) patients with urgency urinary incontinence long-term outcomes comparable to other treatment options, including percutaneous tibial nerve stimulation.įindings of a study published in Urology 1 imply OAB treatment with the investigational eCoin (Valencia Technologies Corp) device is safe and achieves a durable response, says the study’s lead author, urologist Peter Gilling, MD, of Tauranga Urology Research Ltd, Tauranga, New Zealand.

Bladder stimulator